LOVFF.US Cannara Biotech Inc

Healthcare Pharmaceuticals USA Stocks
1.43 USD
Close of Nov 15, 2026
1.11 1.66
Market cap
USD 141M
P/E
17.9x
P/B
1.60x
ROE
8.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to May 2026.

Is LOVFF.US undervalued?

Graham number
Price1.43
Graham value1.27
Premium12.7%

LOVFF.US trades 12.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cannara Biotech Inc fundamental analysis

No fundamental analysis for Cannara Biotech Inc yet.

Cannara Biotech Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cannara Biotech Inc

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was in…

Full company profile